ZA64 25mg Pill — WHITE CAPSULE, 19mm — Topiramate

ZA64 pill photo
View full Topiramate profile
ImprintZA64 / 25mg
ColourWHITE
ShapeCAPSULE
Size19
StrengthTOPIRAMATE 25 mg
Dosage formC42896
ManufacturerZydus Pharmaceuticals (USA) Inc.
NDC68382-005
Schedule—
AvailabilityPrescription only
IngredientsTOPIRAMATE[TOPIRAMATE]

What does this imprint mean?

The imprint "ZA64 25mg" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Topiramate

Uses and warnings

No boxed warning; contraindications are listed as "none." Major warnings include "acute myopia and secondary angle closure glaucoma," which can cause "permanent vision loss" if untreated; "fetal toxicity," as use "during pregnancy can cause cleft lip and/or cleft palate"; "metabolic acidosis" from decreased serum bicarbonate, which can be severe; the class-wide warning that "antiepileptic drugs increase the risk of suicidal thoughts or behavior"; and "oligohidrosis and hyperthermia," primarily reported in pediatric patients, requiring monitoring for decreased sweating and elevated body temperature.

Topiramate tablets are indicated for: - "Initial monotherapy" in patients ≥2 years with partial-onset or primary generalized tonic-clonic seizures - "Adjunctive therapy" in adults and pediatric patients 2-16 years with partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome - "Prophylaxis of migraine headache" in adults

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Topiramate

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 5cca6ad6-6a50-4986-85dd-00f66499697d.xml